OnKure Therapeutics, Inc. - Class A Common Stock

Share · US68277Q1058 · OKUR (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

03.11.2025 21:00

Current Prices from OnKure Therapeutics, Inc. - Class A Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	OKUR	USD	03.11.2025 21:00	3,27 USD	-0,12 USD -3,54 %

Share Float & Liquidity

Free Float 59,15 %

Shares Float 8 M

Shares Outstanding 13,53 M

Company Profile for OnKure Therapeutics, Inc. - Class A Common Stock Share

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.

Get up to date insights from finAgent about OnKure Therapeutics, Inc. - Class A Common Stock

Company Data

Name OnKure Therapeutics, Inc. - Class A Common Stock

Company OnKure Therapeutics, Inc.

Symbol OKUR

Website https://onkuretherapeutics.com

Primary Exchange

NASDAQ

ISIN US68277Q1058

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Nicholas A. Saccomano

Market Capitalization 46 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 6707 Winchester Circle, 80301 Boulder

ID Changes

Date	From	To
07.10.2024	RPHM	OKUR

Ticker Symbols

Name	Symbol
NASDAQ	OKUR

More Shares

Investors who hold OnKure Therapeutics, Inc. - Class A Common Stock also have the following shares in their portfolio:

AMUNDI INDEX MSCI EUROPE SRI - IE (C) ETF

GRANITE MORTGAGES 04-3 PLC SER 1 A1 FRN 20/09/25 $ Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog